Evidence map›Paper›PMID 33247362›Full record

Observational studyAnnals of surgical oncology2021

Factors that Influence Treatment Delay for Patients with Breast Cancer.

María Padilla-Ruiz, Irene Zarcos-Pedrinaci, Francisco Rivas-Ruiz, Teresa Téllez, Susana García-Gutiérrez, Nerea González, Amado Rivero, Cristina Sarasqueta, Pedro Serrano-Aguilar, Xavier Castells and 49 more

Abstract readMulticenter StudyObservational Study
PubMed Publisher
In one paragraph

Observational study in Annals of surgical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Observational
  5. Comparison of oncological care in a hospital center before and after the integration of specialized oncology services.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

59 authors at 6 institutions in 2 countries.

María Padilla-RuizResearch Unit, Agencia Sanitaria Costa del Sol, Hospital Costa del Sol University of Málaga, Marbella, Spain.ORCID http://orcid.org/0000-0002-2321-9211
Irene Zarcos-PedrinaciOncology Service, Hospital Costa del Sol, Marbella, Spain.
Francisco Rivas-RuizResearch Unit, Agencia Sanitaria Costa del Sol, Hospital Costa del Sol University of Málaga, Marbella, Spain.ORCID http://orcid.org/0000-0002-8894-0501
Teresa TéllezHealth Services Network for Research into Chronic Diseases (REDISSEC), Madrid, Spain.
Susana García-GutiérrezHealth Services Network for Research into Chronic Diseases (REDISSEC), Madrid, Spain.ORCID http://orcid.org/0000-0002-8474-2479
Nerea GonzálezHealth Services Network for Research into Chronic Diseases (REDISSEC), Madrid, Spain.ORCID http://orcid.org/0000-0003-3928-3274
Amado RiveroHealth Services Network for Research into Chronic Diseases (REDISSEC), Madrid, Spain.ORCID http://orcid.org/0000-0002-5067-3196
Cristina SarasquetaUnidad de Investigación, Instituto de Investigación Sanitaria BioDonostia, Hospital Universitario Donostia - REDISSEC, Donostia, Gipuzkoa, Spain.
Pedro Serrano-AguilarHealth Services Network for Research into Chronic Diseases (REDISSEC), Madrid, Spain.
Xavier CastellsHealth Services Network for Research into Chronic Diseases (REDISSEC), Madrid, Spain.ORCID http://orcid.org/0000-0002-2528-0382
José María QuintanaHealth Services Network for Research into Chronic Diseases (REDISSEC), Madrid, Spain.ORCID http://orcid.org/0000-0003-2170-7876
María SalaHealth Services Network for Research into Chronic Diseases (REDISSEC), Madrid, Spain.ORCID http://orcid.org/0000-0002-9955-8746
Maximino RedondoResearch Unit, Agencia Sanitaria Costa del Sol, Hospital Costa del Sol University of Málaga, Marbella, Spain. prmariac@gmail.com.ORCID http://orcid.org/0000-0001-5559-4246
REDISSEC-CaMISS Group
Xavier Castells
Mercè Comas
Laia Domingo
Francesc Macià
Marta Roman
Anabel Romero
María Sala
Teresa Barata
Isabel Diez de la Lastra
Mariola de la Vega
Marisa Bare
Núria Torà
Joana Ferrer
Francesc Castanyer
Carmen Carmona
Susana García
Maximina Martín
Nerea González
Miren Orive
María Amparo Valverde
Alberto Saez
Inma Barredo
Manuel de Toro
Josefa Ferreiro
Jose María Quintana
Jeanette Pérez
Amado Rivero
Cristina Valcárcel
María Padilla
Maximino Redondo
Teresa Téllez
Irene Zarcos
Cristina Churruca
Amaia Perales
Javier Recio
Irune Ruiz
Cristina Sarasqueta
Jose María Urraca
Ma Jesús Michelena
Julio Moreno
Gaizka Mallabiabarrena
Patricia Cobos
Borja Otero
Javier Gorostiaga
Itsaso Troya
Hospital de Galdakao · ESUniversitat Autònoma de Barcelona · ESBiogipuzkoa Health Research Institute · ESHospital Costa del Sol · ESFundación Canaria de Investigación Sanitaria · ESServicio Canario de la Salud · ES

Funding

Instituto de Salud Carlos III PI12/01842, PI12/02493Ministerio de Salud de Andalucía "16/298"
6 · The paper itself

Abstract

introductionThe diagnosis or treatment of breast cancer is sometimes delayed. A lengthy delay may have a negative psychological impact on patients. The aim of our study was to evaluate the sociodemographic, clinical and pathological factors associated with delay in the provision of surgical treatment for localised breast cancer, in a prospective cohort of patients.

methodsThis observational, prospective, multicentre study was conducted in ten hospitals belonging to the Spanish national public health system, located in four Autonomous Communities (regions). The study included 1236 patients, diagnosed through a screening programme or found to be symptomatic, between April 2013 and May 2015. The study variables analysed included each patient's personal history, care situation, tumour history and data on the surgical intervention, pathological anatomy, hospital admission and follow-up. Treatment delay was defined as more than 30 days elapsed between biopsy and surgery.

resultsOver half of the study population experienced surgical treatment delay. This delay was greater for patients with no formal education and among widows, persons not requiring assistance for usual activities, those experiencing anxiety or depression, those who had a high BMI or an above-average number of comorbidities, those who were symptomatic, who did not receive NMR spectroscopy, who presented a histology other than infiltrating ductal carcinoma or who had poorly differentiated carcinomas.

conclusionsCertain sociodemographic and clinical variables are associated with surgical treatment delay. This study identifies factors that influence surgical delays, highlighting the importance of preventing these factors and of raising awareness among the population at risk and among health personnel.

Indexed as

Breast NeoplasmsComorbidityFemaleHospitalsHumansProspective StudiesTime-to-Treatment

Identifiers

PMID33247362
OpenAlexW3109138943

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.